Due to the autoinflammatory nature of Still’s disease [9], deeper analysis on how IL-1 vs. IL6R blockers may affect the innate immune system was performed by modeling their mechanisms of action in detail, which were later biologically validated with expression data. This evidence concerns the gene IL6R and systemic-onset juvenile idiopathic arthritis.